Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
If you are concerned about any side effects, please contact one of our clinicians or your GP
Collectively, these data suggest that beyond its primary role in reducing body weight, RYGB improved the systemic glycemic control and the brain glucose uptake of the patients
Reinitiation Criteria: Clinicians should consider increasing the dose or reinitiating therapy if a patient experiences more than 5% weight regain
Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel J-C, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG
Participants in the Phase 2 trials have achieved an average weight reduction of up to 14.7% over 36 weeks
Essential products make up 6065% of the companys portfolio with the remainder being non-essential items
